Free Case Evaluation
FILL OUT THE FORM BELOW
TO REQUEST YOUR CASE REVIEW
Latest Hair Relaxer Lawsuit Updates
Our attorneys are reviewing claims from women diagnosed with uterine cancer, endometrial cancer, ovarian cancer, or uterine fibroids after long-term use of chemical hair relaxers and straighteners.
Hair relaxer claims are consolidated in MDL 3060, In re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation, in the U.S. District Court for the Northern District of Illinois before Judge Mary M. Rowland.
To qualify, claimants generally need a documented cancer diagnosis (uterine, endometrial, or ovarian) or a uterine fibroid diagnosis with surgical intervention, plus a multi-year history of relaxer use.
Fill out the form to check your eligibility and find out if you qualify to file a claim.
The litigation alleges that L'Oreal USA, Strength of Nature, Dabur International, Revlon, Namaste Laboratories, and Soft Sheen Carson sold chemical relaxers containing endocrine-disrupting compounds (phthalates, parabens, formaldehyde-releasing preservatives, and di-2-ethylhexyl phthalate) without warning consumers of the cancer risk.
Diagnoses being investigated by hair relaxer attorneys:
- Uterine Cancer (endometrial adenocarcinoma, FIGO Stage I through IV)
- Endometrial Cancer (Type I and Type II endometrial carcinoma)
- Ovarian Cancer (epithelial, including high-grade serous)
- Uterine Fibroids (leiomyomata) requiring hysterectomy, myomectomy, or uterine artery embolization
- Uterine Sarcoma (leiomyosarcoma, endometrial stromal sarcoma)
- Breast Cancer (subset of cases under review)
MDL 3060 Update: The Plaintiffs' Steering Committee filed an amended Master Long-Form Complaint, and bellwether discovery is underway. The case docket continues to expand as new plaintiffs join.
The catalyst for the litigation was the October 2022 National Institutes of Health Sister Study (Chang et al., JNCI), which found that women using chemical hair straighteners more than four times per year had roughly 2.5 times the risk of uterine cancer compared to non-users.
Table of Contents
[show]- Cancers and Conditions Linked to Hair Relaxers
- The Science: NIH Sister Study and Boston University BWHS
- Named Defendants and Products at Issue
- MDL 3060 Status: Court, Judge, and Procedural Posture
- Who Qualifies to File a Hair Relaxer Lawsuit
- Compensation Available in Hair Relaxer Claims
- How to File: Statute of Limitations and Next Steps
Hair Relaxer Cancer Lawsuits: Who is Filing and Why
(Chemical Hair Straightener Litigation, May 2026)
Chemical hair relaxers have been marketed primarily to Black women and girls for decades, often used continuously from childhood. The products contain compounds that absorb through the scalp (a uniquely permeable skin region) and act as xenoestrogens that disrupt the endocrine system.
The phrase that searchers most often type into Google ("Black women hair relaxer lawsuit") reflects the reality of who is filing. The plaintiff pool in MDL 3060 is overwhelmingly Black women whose mothers, grandmothers, and salons used L'Oreal Dark and Lovely, Strength of Nature Just for Me (a children's relaxer marketed to girls as young as five), Soft Sheen Carson Optimum, ORS Olive Oil, and Revlon Creme of Nature throughout their lives.
Plaintiffs allege the manufacturers knew or should have known about the cancer risk and failed to warn consumers.
The first individual case was filed in October 2022 by Jenny Mitchell in the Northern District of Illinois, alleging uterine cancer caused by 25 years of relaxer use. Her filing came shortly after the NIH Sister Study results were published.
Within months, hundreds of similar cases were filed and consolidated into MDL 3060.
Compensation in successful claims may include medical expenses for cancer treatment, surgical costs, lost income, future care, pain and suffering, and in fatal cases, wrongful death damages on behalf of surviving family.
Why Hair Relaxer Cancer Claims Are Being Taken Seriously
The litigation rests on epidemiological evidence connecting chemical relaxer use to hormone-driven cancers.
Hair relaxers chemically alter the protein structure of curly and coily hair. To do that, the products contain harsh active ingredients (lye, sodium hydroxide, calcium hydroxide, guanidine) along with fragrances, preservatives, and stabilizers. Many of those secondary compounds are known endocrine disruptors.
Endocrine disruption is the mechanism. The endometrium and ovaries are hormone-sensitive tissues. When chemicals that mimic or block estrogen are absorbed repeatedly over years, the cumulative exposure can drive cellular changes that lead to uterine and ovarian cancers.
The 2022 Sister Study tracked nearly 33,500 women over 11 years. Women using chemical hair straighteners more than four times per year had a 2.55-fold increased risk of uterine cancer. The signal was strongest among Black women, who reported the highest rates of relaxer use.
A 2023 follow-up from the Boston University Black Women's Health Study (BWHS) reinforced the finding, reporting elevated uterine cancer risk among long-term postmenopausal users of chemical relaxers.
- Two large cohort studies (NIH Sister Study and BU BWHS) point in the same direction
- Manufacturers documented internal knowledge of phthalate and formaldehyde concerns going back years
- Plaintiffs include young women diagnosed with cancers typically seen decades later
- MDL 3060 was centralized within months of the first filings, signaling judicial recognition of common questions
The Science Behind the Claims
The Sister Study (Chang JL, et al., J Natl Cancer Inst, 2022) is the landmark study. It examined 33,497 U.S. women aged 35 to 74 over 10.9 years of follow-up. The researchers identified 378 uterine cancer cases.
The result: women who used chemical hair straighteners more than four times in the prior year had an adjusted hazard ratio of 2.55 for uterine cancer compared to never-users.
The Sister Study did not isolate by race, but the authors noted that Black women reported the highest frequency of use and would carry a disproportionate share of the elevated risk.
Active Compounds at Issue
Hard Truth: Plaintiffs allege the cancer risk traces to several specific ingredients common in relaxer formulations. Di-2-ethylhexyl phthalate (DEHP) and other phthalates act as plasticizers and fragrance carriers. Parabens (methylparaben, propylparaben) preserve the product. Formaldehyde-releasing preservatives such as DMDM hydantoin slowly release formaldehyde, a known human carcinogen. Bisphenol A (BPA) appears in some packaging. All are documented endocrine disruptors.
The Sister Study Findings in Plain Numbers
Hard Truth: Among the 33,497 women followed, 1.64% of frequent users developed uterine cancer compared to 0.66% of non-users by age 70. The 2.55-fold relative risk translates to roughly one additional uterine cancer per 100 frequent users over a lifetime. For a product used by millions of women, that is a substantial absolute number of cases.
Boston University Black Women's Health Study
Hard Truth: The BWHS, a long-running cohort of nearly 60,000 Black women, reported in 2023 that postmenopausal women who used chemical relaxers heavily and for many years had elevated uterine cancer risk. The study added population-specific weight to the Sister Study findings and is cited in the master complaint.
Named Defendants and Brand Products at Issue
The amended Master Complaint in MDL 3060 names a defined set of manufacturers and a long list of consumer products. The most frequently identified products in plaintiff fact sheets include:
Defendants and Their Hair Relaxer Brands
L'Oreal USA is the largest defendant by volume of branded products. Brands named in the litigation include Dark and Lovely, Optimum Care, and the Soft Sheen Carson product line acquired by L'Oreal. L'Oreal denies the allegations and has moved to dismiss on preemption and general causation grounds.
Strength of Nature LLC manufactures African Pride, Profectiv Mega Growth, Just for Me, and other relaxer brands marketed heavily to Black women and to children. The "Just for Me" line, formulated for children as young as five, has drawn particular scrutiny in plaintiff filings.
Soft Sheen Carson, a L'Oreal subsidiary, produced Optimum Care, Optimum Salon Haircare, and the long-running Dark and Lovely no-lye relaxer line. Many plaintiffs report decades of use starting in childhood.
Namaste Laboratories, owned by Dabur International, produced ORS Olive Oil relaxer kits and related products. Revlon is also named for its Creme of Nature line. The defendant group reflects the concentrated market share among a handful of corporate parents.
Why the Defendants Are Being Pursued Together
The MDL structure consolidates pretrial proceedings (discovery, expert challenges, bellwether trials) for cases that share common factual and legal questions. It does not merge the individual claims into a single class action.
Each plaintiff retains her own case, her own injury, and her own potential settlement value. The MDL coordinates the work that would otherwise be duplicated across thousands of separate filings.
For hair relaxer plaintiffs, common questions include: Did the manufacturers know about the phthalate, paraben, and formaldehyde risk? Did they warn? Is the science strong enough to prove general causation? Once those questions are resolved at the MDL level, individual cases proceed on specific causation and damages.
HARD TRUTH: The defendants have substantial litigation budgets and have already filed motions challenging general causation, federal preemption, and the admissibility of the Sister Study under Daubert. These fights take time. Patience is part of the process.
MDL 3060 at a Glance
Key procedural facts every claimant should understand:
- Case caption: In re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation, MDL No. 3060
- Court: U.S. District Court for the Northern District of Illinois
- Judge: Hon. Mary M. Rowland
- Centralization order: February 6, 2023, by the Judicial Panel on Multidistrict Litigation
- Lead plaintiff (first filing): Jenny Mitchell, October 2022
- Master complaint: Filed and amended; bellwether selection in progress
- Pending cases: Continuing to grow, with new plaintiffs joining each month
Bellwether trials are early test cases selected from the larger pool. Their verdicts and settlement values often shape resolution of the entire MDL. Hair relaxer bellwether selection is in active discovery.
Who Qualifies to File a Hair Relaxer Lawsuit
Eligibility centers on three things: a qualifying diagnosis, a documented history of relaxer use, and timely filing under your state's statute of limitations.
- Qualifying diagnosis: Uterine cancer, endometrial cancer, ovarian cancer, uterine sarcoma, or uterine fibroids requiring hysterectomy or myomectomy
- Use history: Multi-year use of chemical hair relaxers (most claimants report 5 or more years; many report use beginning in childhood)
- Brand identification: Recall of specific products used (receipts, photos, packaging, prescription records, salon records all help)
- Diagnosis date: Diagnosis within the discovery-rule window for your state
- Causation: No alternative cancer cause that fully explains the diagnosis (BRCA mutation, Lynch syndrome, prior radiation, and similar factors are reviewed case by case)
Even if your records are incomplete, share what you have. Brand identification can be reconstructed through pharmacy histories, salon records, family memory, and photographs. Our intake team helps build the timeline.
Compensation Available in a Hair Relaxer Cancer Claim
Damages in a successful product-liability claim cover both economic and non-economic losses.
Economic damages include past and future medical expenses (chemotherapy, radiation, surgery, follow-up imaging, ongoing oncology care), lost wages during treatment, lost earning capacity if the cancer ended a career, and out-of-pocket costs.
Non-economic damages cover pain and suffering, emotional distress, loss of fertility, loss of consortium, and the diminished quality of life that follows a cancer diagnosis.
In wrongful death cases, surviving family members may recover funeral costs, loss of financial support, loss of companionship, and the decedent's own pre-death pain and suffering through a survival action.
Punitive damages remain on the table where evidence supports a finding that the manufacturers knew about the risk and continued to market the products without warning.
What Hair Relaxer Settlement Values May Look Like
It is too early to project specific settlement tiers. Bellwether trials have not yet returned verdicts. Comparable mass torts (talc-ovarian cancer, Roundup, Zantac) have produced individual recoveries ranging from tens of thousands to millions of dollars, with values turning on cancer stage, treatment burden, age, and earning history. We track those values across other active toxic-exposure cancer cases our firm is reviewing.
Stage IV diagnoses, hysterectomies in young women with future fertility loss, and wrongful death claims tend to anchor the higher end of any matrix that emerges.
For a deeper look at how injury claims are valued generally, see our guide to what your injury case is worth and the multiplier method and per diem method insurers and juries use.
Statute of Limitations and Filing Deadlines
Most states apply a discovery rule for latent-injury product cases. The clock starts when a reasonable person would have connected the cancer to the product, not on the date of first use. The 2022 Sister Study publication is a common reference point. Many women diagnosed years earlier are still within their filing window.
Product-liability statutes of limitations range from 1 year (Louisiana, Tennessee) to 6 years (Maine, North Dakota). Many states fall at 2 or 3 years. Statutes of repose, where they exist, can also bar claims regardless of when the cancer was discovered. Your state matters. Get a case review to confirm your filing window.
If a loved one died of uterine, endometrial, or ovarian cancer linked to relaxer use, the wrongful death clock typically starts at the date of death, not the diagnosis date. Surviving spouses, children, and in some states, parents have standing. See our overview of wrongful death claims.
Once a claim is registered in MDL 3060 through a direct filing or short-form complaint, certain tolling protections may apply. Filing earlier rather than later preserves rights and locks in your bellwether-selection eligibility.
Defenses and Hurdles in Hair Relaxer Litigation
The defendants are not conceding anything. Expect contested motions on three fronts.
First, federal preemption. The defendants have argued that FDA cosmetic regulation preempts state-law failure-to-warn claims. Cosmetics are regulated more loosely than drugs, so the preemption argument is harder to win, but it has been raised.
Second, general causation. The defendants will challenge the Sister Study and BWHS findings under Daubert, arguing that observational cohort data does not establish causation at the level required for a tort verdict. Plaintiffs will defend the studies and add expert testimony on biological plausibility.
Third, brand and product identification. With multiple manufacturers and products in the market, the defendants will contest individual plaintiffs' ability to prove which specific brand caused which specific cancer. Documentation of use history is critical.
None of these defenses defeat the litigation. They shape the scope, the timeline, and the eventual settlement values. The defense playbook here mirrors what defendants run in other toxic-exposure cancer cases such as the Roundup non-Hodgkin lymphoma litigation and the AFFF firefighting foam PFAS litigation: contest causation, contest exposure, contest the science.
How to File a Hair Relaxer Lawsuit
The process is straightforward when you work with a firm familiar with MDL 3060.
Step one: free case review. Share your diagnosis, your relaxer history, and the brands you remember using. There is no cost and no obligation.
Step two: medical-record collection. We obtain the pathology reports, surgical records, and oncology notes that document the qualifying diagnosis.
Step three: filing. Most cases are filed directly in MDL 3060 in the Northern District of Illinois under the court's direct-filing order, which preserves any home-state-law advantages.
Step four: plaintiff fact sheet. The MDL requires a detailed fact sheet documenting use history, brand identification, medical history, and family cancer history. We complete this with you.
Step five: discovery and resolution. Depending on bellwether trial outcomes and settlement negotiations, individual cases resolve through verdict, individual settlement, or a global settlement matrix.
You pay nothing out of pocket. Hair relaxer cases are handled on contingency: no fee unless you win.
Time Pressure: Why Sooner Is Better Than Later
Cancer claims under product-liability law are time-bound. Even with the discovery rule, every state has an outer limit. Some states have statutes of repose that close the door entirely after a fixed number of years from product purchase, regardless of when the cancer appeared.
Memory and documentation also fade. The brands you used twenty years ago are easier to identify today than they will be in another two years.
If you are weighing whether to call, call. The case review is free. The conversation does not commit you to anything. Waiting can cost the case.
Hair Relaxer Lawsuit: Frequently Asked Questions
- Q: Do hair relaxers cause cancer?
-
A: The 2022 NIH Sister Study (Chang et al., JNCI) found women who used chemical hair straighteners more than four times per year had 2.55 times the risk of uterine cancer compared to non-users. The 2023 Boston University Black Women's Health Study reinforced the finding. The plaintiffs' theory is that endocrine-disrupting compounds in relaxers (phthalates, parabens, formaldehyde-releasing preservatives, DEHP) absorb through the scalp and act as xenoestrogens that drive hormone-sensitive cancers. Causation is contested, but the evidence base is strong enough to support the litigation.
- Q: What is the average hair relaxer settlement amount?
-
A: No global settlement matrix has been finalized in MDL 3060, so a true average does not yet exist. Comparable hormone-sensitive cancer mass torts (talc-ovarian, transvaginal mesh) have produced individual recoveries from the low five figures for early-stage cases up to seven and eight figures for Stage IV diagnoses, hysterectomy in young women, and wrongful death. Final values will turn on cancer stage, treatment burden, age at diagnosis, and the strength of brand identification. Bellwether verdicts will set the floor.
- Q: What hair relaxer brands are part of the lawsuit?
-
A: Brands named in the master complaint include Dark and Lovely (L'Oreal / Soft Sheen Carson), Optimum Care (Soft Sheen Carson), Just for Me (Strength of Nature, marketed to children), African Pride and Profectiv Mega Growth (Strength of Nature), ORS Olive Oil (Namaste / Dabur), Creme of Nature (Revlon), and Motions and TCB (Strength of Nature). If you used any of these brands long-term and were diagnosed with uterine, endometrial, or ovarian cancer, a hair relaxer attorney can help you confirm eligibility.
- Q: I had a hysterectomy because of fibroids. Do I have a claim?
-
A: Possibly yes. Uterine fibroid claims with documented hysterectomy or myomectomy are part of MDL 3060 and align with the elevated fibroid risk reported in the BWHS. Fibroid-only cases (without cancer) are reviewed case by case. The strength of the claim depends on use history, surgical records, and whether the fibroids met criteria that necessitated surgery. Speak with a hair relaxer lawyer to evaluate the specifics.
- Q: Can men file a hair relaxer lawsuit?
-
A: The MDL is built around uterine, endometrial, and ovarian cancer claims, all of which are female-specific. Men are not the plaintiff population. The litigation does not currently accept male plaintiffs.
- Q: What if my mother or grandmother died of uterine cancer?
-
A: Surviving family members may pursue a wrongful death claim and a survival action when a relaxer-linked cancer was fatal. The wrongful death clock typically starts at the date of death, not the diagnosis date. Surviving spouses, children, and (in some states) parents have standing. See our overview of wrongful death claims for state-specific eligibility.
- Q: How do I find a hair relaxer attorney near me?
-
A: Most hair relaxer cases are filed directly in MDL 3060 in the Northern District of Illinois under the court's direct-filing order. That means you do not need an attorney physically located in your home state. You need a hair relaxer law firm with MDL experience, the resources to fund a multi-year case, and a documented relationship with the plaintiffs' steering committee handling the litigation. The case review is free.
- Q: What does a hair relaxer lawyer cost?
-
A: Contingency fee. You pay no out-of-pocket fees. Attorney fees come from money recovered in your case. If we do not recover, you owe nothing. This is the standard structure for product-liability cases.
Talk to a Hair Relaxer Lawyer Today
If you used chemical hair relaxers and were later diagnosed with uterine cancer, endometrial cancer, ovarian cancer, uterine sarcoma, or uterine fibroids requiring surgery, you may qualify to file a claim in MDL 3060.
Our team handles hair relaxer cases on contingency. You pay no legal fees unless we recover compensation for you.
The case review is free, confidential, and carries no obligation. Share your diagnosis and use history with our intake team and find out what your options look like.
Free Case Evaluation
FILL OUT THE FORM BELOW
TO REQUEST YOUR CASE REVIEW
External Resources
Legal Representation
"Speak with our hair relaxer claims attorney for a free, confidential review of your potential claim. Past results vary based on the unique facts of each case."
Find out more >>